Timothy J Wilkin MD
Associate Professor, Medicine, Weill Cornell Medical College
Join to View Full Profile
4168 Front StSan Diego, CA 92103
Phone+1 800-926-8273
Dr. Wilkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 1999 - 2002
University of ChicagoResidency, Internal Medicine, 1996 - 1999
Ohio State University College of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 2024 - 2026
NY State Medical License 1999 - 2026
IL State Medical License 1996 - 1999
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
Clinical Trials
- Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection Start of enrollment: 2007 Nov 01
- Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression Start of enrollment: 2009 Jan 01
- HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women Start of enrollment: 2012 Apr 04
Publications & Presentations
PubMed
- 1 citationsClinical Consequences of Delaying Implementation of Long-Acting Antiretroviral Therapy for People With HIV and Persistent Viremia in the United States.Pamela P Pei, Michelle Jones, Ruitian Hu, Wanyi Chen, Paul E Sax
Clinical Infectious Diseases. 2026-02-04 - Health-Related Quality of Life for Persons Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (AMC-A01).Thomas M Atkinson, Madhu Mazumdar, Grace Van Hyfte, Jeannette Y Lee, Yuelin Li
JCO Oncology Practice. 2025-10-01 - Design of a multicenter, randomized, double-blinded, placebo-controlled phase III trial evaluating the 9-valent human papillomavirus (HPV) vaccine to prevent persisten...Anna R Giuliano, Anna Beltrame, Luisa L Villa, Eduardo Lazcano-Ponce, Jorge Santana-Bagur
Vaccine. 2025-08-13
Journal Articles
- Initial Development and Content Validation of a Health-Related Symptom Index for Persons Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial LesionsTimothy J Wilkin, Joel M Palefsky, Value in Health
- A Randomized Clinical Trial of Infrared Coagulation Ablation Versus Active Monitoring of Intra-Anal High-Grade Dysplasia in HIV-Infected Adults: An AIDS Malignancy Con...Timothy Wilkin, Jeannette Y Lee, Stephen E Goldstone, Clinical Infectious Diseases
Authored Content
- Initial Development and Content Validation of a Health-Related Symptom Index for Persons Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial LesionsAugust 2018
Press Mentions
Tpoxx Doesn’t Improve on Placebo in Achieving Key Mpox Outcomes, Phase 3 Trial ConcludesFebruary 26th, 2026- HIV Patients Fare Well with Mpox TreatmentMay 5th, 2023
- NIH Grant to Improve HIV-Related Cancer Care AbroadFebruary 3rd, 2023
Grant Support
- Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)UNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- UCSD Collaborative Clinical Trials UnitUNIVERSITY OF CALIFORNIA, SAN DIEGO2007–2027
- Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto RicoWEILL MEDICAL COLL OF CORNELL UNIV2019–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
